ConductScience.org, home

Paper40524972

Evaluating the Diagnostic and Prognostic Value of Peripheral Immune Markers in Glioma Patients: A Prospective Multi-Institutional Cohort Study of 1282 Patients.

Lu J and 8 others. J Inflamm Res, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Evaluating the Diagnostic and Prognostic Value of Peripheral Immune Markers in Glioma Patients: A Prospective Multi-Institutional Cohort Study of 1282 Patients. Papers, record 40524972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40524972

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluating the Diagnostic and Prognostic Value of Peripheral Immune Markers in Glioma Patients: A Prospective Multi-Institutional Cohort Study of 1282 Patients.
PubMed
Journal
J Inflamm Res
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-06-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu JJiehttps://orcid.org/0000-0002-8345-9954
2Zhang ZYZhi-Yun
3Zhong SSheng
4Deng DDavy
5Yang WZWen-Zhuo
6Wu SWSu-Wen
7Cheng YYe
8Bai YYang
9Mou YGYong-Gao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123564577Complement in immune and inflammatory disorders: pathophysiological mechanisms.J Immunol2013https://conductscience.org/library/papers/23564577PubMed
238720342Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.J Hematol Oncol2024https://conductscience.org/library/papers/38720342PubMed
329175722Significance of systemic immune-inflammation index in the differential diagnosis of high- and low-grade gliomas.Clin Neurol Neurosurg2018https://conductscience.org/library/papers/29175722PubMed
432542437Immune suppression in gliomas.J Neurooncol2021https://conductscience.org/library/papers/32542437PubMed
531787848Role of the complement system in the tumor microenvironment.Cancer Cell Int2019https://conductscience.org/library/papers/31787848PubMed
626583100T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview.Biomed Res Int2015https://conductscience.org/library/papers/26583100PubMed
736809318Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.JAMA2023https://conductscience.org/library/papers/36809318PubMed
830683134MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma.J Exp Clin Cancer Res2019https://conductscience.org/library/papers/30683134PubMed
931152305Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell lines.J Neurooncol2019https://conductscience.org/library/papers/31152305PubMed
1030208949The complement system in glioblastoma multiforme.Acta Neuropathol Commun2018https://conductscience.org/library/papers/30208949PubMed
1131530559Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma.Cancer Immunol Res2019https://conductscience.org/library/papers/31530559PubMed
1239179536Natural Killer cells at the frontline in the fight against cancer.Cell Death Dis2024https://conductscience.org/library/papers/39179536PubMed
1329437767T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.Clin Cancer Res2018https://conductscience.org/library/papers/29437767PubMed
1424045166
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level.
J Neuroimmunol2013https://conductscience.org/library/papers/24045166PubMed
1525253418Circulating glioma biomarkers.Neuro Oncol2015https://conductscience.org/library/papers/25253418PubMed
1632198351Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity.Nat Commun2020https://conductscience.org/library/papers/32198351PubMed
1727437104B cell regulation of the anti-tumor response and role in carcinogenesis.J Immunother Cancer2016https://conductscience.org/library/papers/27437104PubMed
1828626234B cell regulation in cancer and anti-tumor immunity.Cell Mol Immunol2017https://conductscience.org/library/papers/28626234PubMed
1915977639Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.J Neuropathol Exp Neurol2005https://conductscience.org/library/papers/15977639PubMed
2022397650Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.N Engl J Med2012https://conductscience.org/library/papers/22397650PubMed

See all 39 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42308424Machine learning-guided multimodal profiling defines perturbed immune states at the time of cancer diagnosis.Brief Bioinform2026https://conductscience.org/library/papers/42308424PubMed
41374965Advances in Artificial Intelligence for Glioblastoma Radiotherapy Planning and Treatment.Cancers (Basel)2025https://conductscience.org/library/papers/41374965PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40524972

GET https://conductscience.org/api/papers/v1/40524972/references?page=2